Peggy Sotiropoulou

Company: T-knife Therapeutics

Job title: Chief Scientific Officer

Seminars:

Combining Best-in-Class TCRs, Next Generation Technologies & Optimal Manufacturing to Mediate Optimal Anti-Tumor Response 3:30 pm

MyT platformTM, a unique T-cell receptor and unbiased epitope discovery engine Next-generation approaches to engage the broader immune system and promote resistance to the tumor microenvironment Process development that selects for memory phenotypeRead more

day: Conference Day Two

Industry Leaders’ Fireside Chat: What’s Next for T-Cell Receptor Therapies? 8:30 am

Appreciating the wealth of TCR therapy advances and exploring the data to secure clinical validation Examining the range of TCR modalities and their respective targeting benefits Discussing the advances in allogeneic TCR approaches to determine the future directions for TCR therapiesRead more

day: Conference Day One